Psychiatry · Marietta, GA
NPI
1881771004
Since 2006
Specialty
Psychiatry
Code 2084P0800X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
1012 Coggins Pl NE
Marietta, GA, 30060
Phone (770) 422-2009
Groups this clinician bills Medicare through
Medicare paid, 2024
$340K
1,744 services
Medicare patients, 2024
204
Average age 68
Drug cost, 2024
$1.1M
5,113 prescriptions
Company payments, 2025
$158K
From 24 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michael D Banov was code 90868 (treatment - miscellaneous), 546 times for 18 patients. In total Michael D Banov billed 1,744 services in 15 codes, and Medicare paid $340K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-03-23.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 90868 Treatment - Miscellaneous | Office | 546 | 18 | $134.65 | $74K |
| 96127 Behavioral Health Services | Office | 301 | 20 | $3.20 | $962 |
| G2083 Office or other outpatient visit for the evaluation and management of an established patient that requires the supervision of a physician or other qualified health care professional and provision of greater than 56 mg esketamine nasal self-administration, | Office | 242 | 16 | $850.52 | $206K |
| 99214 Office E&M - Established | Office | 179 | 117 | $75.68 | $14K |
| 90833 Psychotherapy - Nongroup | Office | 156 | 96 | $42.15 | $6,576 |
| 99213 Office E&M - Established | Office | 117 | 81 | $52.67 | $6,163 |
| 99215 Office E&M - Established | Office | 106 | 64 | $87.35 | $9,259 |
| 90792 Psychotherapy - Nongroup | Office | 19 | 18 | $106.84 | $2,030 |
| 90867 Treatment - Miscellaneous | Office | 17 | 17 | $243.50 | $4,139 |
By year: 2022 $227K for 1,631 services; 2023 $255K for 1,309 services; 2024 $340K for 1,744 services.
Medicare prescription drug claims, 2024
In 2024, the drug Michael D Banov prescribed most often to Medicare patients was Quetiapine Fumarate, with 317 prescriptions and refills. In total Michael D Banov wrote 5,113 Medicare prescriptions that cost $1.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Quetiapine Fumarate Generic | 317 | 492 | 63 | $6,333 |
| Alprazolam Generic | 253 | 253 | 45 | $1,779 |
| Lamotrigine Generic | 242 | 461 | 46 | $2,236 |
| Trazodone Hcl Generic | 227 | 409 | 57 | $2,536 |
| Bupropion Xl Bupropion Hcl | 212 | 450 | 61 | $4,195 |
| Duloxetine Hcl Generic | 203 | 352 | 38 | $3,793 |
| Clonazepam Generic | 201 | 217 | 35 | $1,140 |
| Fluoxetine Hcl Generic | 170 | 284 | 39 | $998 |
| Venlafaxine Hcl Er Venlafaxine Hcl | 167 | 373 | 39 | $4,517 |
| Zolpidem Tartrate Generic | 164 | 188 | 25 | $834 |
| Aripiprazole Generic | 148 | 276 | 35 | $6,878 |
| Escitalopram Oxalate Generic | 147 | 305 | 39 | $2,269 |
| Olanzapine Generic | 145 | 227 | 25 | $3,564 |
| Gabapentin Generic | 136 | 221 | 27 | $2,211 |
| Desvenlafaxine Succinate Er Desvenlafaxine Succinate | 117 | 177 | 18 | $7,032 |
Brand drugs: 509 claims; generic drugs: 4,604 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Michael D Banov $158K ($158K in general payments such as food, travel and fees) from 24 companies. The largest payer was Axsome Therapeutics, Inc. with $51K.
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. AXSM | 63 | $51K |
| Teva Pharmaceuticals USA, Inc. TEVA | 27 | $32K |
| Janssen Pharmaceuticals, Inc JNJ | 31 | $23K |
| Vanda Pharmaceuticals Inc. VNDA | 33 | $17K |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 30 | $17K |
| Abbvie Inc. ABBV | 40 | $16K |
| E.R. Squibb & Sons, L.L.C. BMY | 12 | $1,545 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 12 | $175 |
| Noven Therapeutics, LLC | 11 | $173 |
| Bausch Health US, LLC BHC | 6 | $133 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.